연구동향 분석

Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of antidiabetic drug

김해진 백은복 김성준 2018년

논문상세정보
    • 저자 김해진 백은복 김성준
    • 제어번호 105942488
    • 학술지명 The Korean Journal of Physiology & Pharmacology
    • 권호사항 Vol. 22 No. 6 [ 2018 ]
    • 발행처 대한약리학회
    • 발행처 URL http://www.koreaphysiol.org
    • 자료유형 학술저널
    • 수록면 713-719
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 강원대학교 춘천캠퍼스 도서관 의학분관 건국대학교 상허기념중앙도서관 경북대학교 도서관 의학분관 경북대학교 도서관 치의학분관 부산대학교 중앙도서관 숙명여자대학교 중앙도서관 이화여자대학교 중앙도서관
    • 판매처
    유사주제 논문( 324)
인용/피인용
' Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of antidiabetic drug' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 약학
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
325 0

0.0%

' Potentiation of endothelium-dependent vasorelaxation of mesenteric arteries from spontaneously hypertensive rats by gemigliptin, a dipeptidyl peptidase-4 inhibitor class of antidiabetic drug' 의 참고문헌

  • Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?
  • The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors
    Dickson SL [2012]
  • The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose
    Salheen SM [2015]
  • Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction
    Esposito G [2017]
  • Reactive oxygen species in endothelial function - from disease to adaptation
    Craige SM [2015]
  • Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
    Incalza MA [2018]
  • Mechanisms for the cardiovascular effects of glucagonlike peptide-1
    Poudyal H [2016]
  • Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice
    Sauvé M [2010]
  • Gemigliptin:newer promising gliptin for type 2 diabetes mellitus
    Gutch M [2017]
  • Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study).
    Park SE [2017]
  • Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature
  • Dipeptidyl peptidase-4inhibitors and GLP-1 reduce myocardial infarct size in a glucosedependent manner
  • Dipeptidyl peptidase-4 inhibitors : clinical data and clinical implications
    Ahrén B. [2007]
  • Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism
    Liu L [2012]
  • DPP-4inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure
    Koibuchi N [2014]
  • Contribution of oxidative stress to endothelial dysfunction in hypertension
    Silva BR [2012]
  • Cardiovascular effects of dipeptidyl peptidase-4 inhibitors
  • Cardiovascular effects of DPP-4 inhibition : beyond GLP-1
    Fadini GP [2011]
  • Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS)Collaborative Research Group
    Newman AB [1993]
  • An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury
    Ihara M [2015]